Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 40 | $22,449,222 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
11 Mar 2024 20:09 | XENE | Xenon Pharmaceuticals Inc | GAROFALO ELIZABETH A. | Director | 08 Mar 2024 | Sale | 2,092 | 45.69 | 95,583 | D |
08 Mar 2024 17:31 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 07 Mar 2024 | Sale | 6,118 | 46.3 | 283,263 | D |
08 Mar 2024 17:31 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 07 Mar 2024 | Sale | 1,019 | 46.15 | 47,027 | D |
08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 2,000 | 46.2012 | 92,402 | D |
08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 5,000 | 46.3025 | 231,512 | D |
08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 5,000 | 46.25 | 231,250 | D |
08 Mar 2024 17:28 | XENE | Xenon Pharmaceuticals Inc | GANNON STEVEN | Director | 07 Mar 2024 | Sale | 1,000 | 46.45 | 46,450 | D |
15 Dec 2023 21:50 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 14 Dec 2023 | Sale A | 7,598 | 41.05 | 311,898 | I |
15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 7,598 | 41.05 | 311,898 | I |
15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 3,977 | 39.84 | 158,444 | D |
15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 2,303 | 39.1 | 90,047 | D |
15 Dec 2023 17:38 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 13 Dec 2023 | Sale | 5,100 | 38.94 | 198,594 | D |
24 Aug 2023 16:33 | XENE | Xenon Pharmaceuticals Inc | SVORONOS DAWN | Director | 24 Aug 2023 | Sale | 25,000 | 38.7 | 967,500 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 01 Jun 2023 | Sale | 24,255 | 38.78 | 940,609 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 01 Jun 2023 | Sale | 7,458 | 38.97 | 290,638 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 31 May 2023 | Sale | 26,856 | 38.69 | 1,039,059 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 31 May 2023 | Sale | 23,670 | 38.81 | 918,633 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 31 May 2023 | Sale | 12,000 | 38.53 | 462,360 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 30 May 2023 | Sale | 19,000 | 39.9 | 758,100 | D |
01 Jun 2023 19:25 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 30 May 2023 | Sale | 18,006 | 38.63 | 695,572 | D |
26 May 2023 19:10 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 May 2023 | Sale | 1,407 | 41.49 | 58,376 | D |
26 May 2023 19:10 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 May 2023 | Sale | 13,179 | 41.37 | 545,215 | D |
26 May 2023 19:10 | XENE | Xenon Pharmaceuticals Inc | MORTIMER IAN | PRESIDENT & CEO | 24 May 2023 | Sale | 17,069 | 41.44 | 707,339 | D |
24 Mar 2023 19:18 | XENE | Xenon Pharmaceuticals Inc | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | 24 Mar 2023 | Sale | 700 | 35.01 | 24,507 | D |
09 Mar 2023 18:21 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 07 Mar 2023 | Sale | 8,242 | 36.94 | 304,459 | D |
09 Mar 2023 18:21 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 07 Mar 2023 | Sale | 10,990 | 37.01 | 406,740 | D |
28 Nov 2022 20:41 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 25 Nov 2022 | Sale | 1,937 | 34.7911 | 67,390 | D |
28 Nov 2022 20:41 | XENE | Xenon Pharmaceuticals Inc | PATOU GARY | Director | 23 Nov 2022 | Sale | 2,057 | 34.3265 | 70,610 | D |
07 Sep 2022 16:26 | XENE | Xenon Pharmaceuticals Inc | AULIN SHERRY | Chief Financial Officer | 02 Sep 2022 | Sale | 15,355 | 39.57 | 607,597 | D |
02 Sep 2022 16:27 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 01 Sep 2022 | Sale | 8,776 | 38.8 | 340,509 | D |
02 Sep 2022 16:27 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 01 Sep 2022 | Sale | 35,103 | 38.03 | 1,334,967 | D |
02 Sep 2022 16:27 | XENE | Xenon Pharmaceuticals Inc | ROBIN SHERRINGTON | EVP, Strategy & Innovation | 31 Aug 2022 | Sale | 21,352 | 38.57 | 823,547 | D |
16 Aug 2022 17:36 | XENE | Xenon Pharmaceuticals Inc | EMPFIELD JAMES R. | EVP, Drug Discovery | 12 Aug 2022 | Sale | 21,875 | 38.68 | 846,125 | D |
16 Aug 2022 17:36 | XENE | Xenon Pharmaceuticals Inc | EMPFIELD JAMES R. | EVP, Drug Discovery | 12 Aug 2022 | Sale | 35,868 | 38.08 | 1,365,853 | D |
16 Aug 2022 17:31 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 16 Aug 2022 | Sale | 20,000 | 38.87 | 777,400 | D |
16 Aug 2022 17:31 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 16 Aug 2022 | Sale | 32,058 | 38.29 | 1,227,501 | D |
16 Aug 2022 17:31 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 15 Aug 2022 | Sale | 33,942 | 37.76 | 1,281,650 | D |
16 Aug 2022 17:31 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 12 Aug 2022 | Sale | 1,000 | 39.15 | 39,150 | D |
16 Aug 2022 17:31 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 12 Aug 2022 | Sale | 47,000 | 38.6 | 1,814,200 | D |
16 Aug 2022 17:31 | XENE | Xenon Pharmaceuticals Inc | PIMSTONE SIMON N. | Director | 12 Aug 2022 | Sale | 43,135 | 37.91 | 1,635,248 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)